Dosimetric Comparison of VMAT Plans by Varying Number of Arcs Forhead and Neck Cancer Patients

Research Article

Austin J Radiol. 2024; 11(1): 1225.

Dosimetric Comparison of VMAT Plans by Varying Number of Arcs Forhead and Neck Cancer Patients

Harijith KR1; Jitendra Nigam2; Silambarasan NS3; Navitha S3*; Piyush Kumar4

1Intern Medical Physicist, SRMS Institute of Medical Science, Department of Radiation Oncology, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly

2Associate Professor cum Medical Physicist, Department of Radiation Oncology, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly

3Assistant Professor cum Medical Physicist, Department of Radiation Oncology, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly

4Professor and Head, Department of Radiation Oncology, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly

*Corresponding author: Navitha Silambarasan Department of Radiation Oncology, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly. Tel: +91 9677760497 Email: navitha.selvi@gmail.com

Received: December 29, 2023 Accepted: February 03, 2024 Published: February 10, 2024

Abstract

Aim: This study is intended to evaluate the plan quality using Volumetric Modulated Arc Therapy by increasing number of arcs.

Materials and Methods: Twenty patients diagnosed with various head and neck cancers were selected for this study. The patients were treated using Varian Truebeam linear accelerator with VMAT dual arc. These patients were replanned using VMAT plans employing one, three, and four arcs through the Varian Eclipse

13.6 treatment planning system. The target delineation and Organ-At-Risk (OAR) contours were done by the radiation oncologist as per RTOG guidelines. With a grid size of 2.5mm, the dose distribution was determined using the Anisotropic Analytic Algorithm (AAA) and the constraints were kept constant across all plans. All plans were optimized using Progressive Resolution Optimizer. Plan quality was assessed using the Conformity Index, Homogeneity Index, and by evaluating the Planning Target Volume (PTV) coverage, D2, D98, D50 and the dose to the OAR using Dose-Volume Histogram (DVH). Monitor units were also evaluated. Two-way evaluation of plan was done; one is by visually checking the isodose coverage and other using DVH. Statistical data were analyzed using a student’s t-test.

Result: Clinically acceptable target coverage was achieved in all plans. The four-arc plan yielded a significant Conformity Index (P<0.05) and Homogeneity Index (P<0.05) compared to other plans. The four- arc plans resulted in a significant dose reduction for PRV (Planning Organ at Risk Volume) Spine, lips and parotid. There was no significant difference between the dose to PRV Brainstem and cochlea. A lower Monitor Unit (MU) per 2.0 Gy per fraction was achieved using 1 Arc (436 MU), 2 Arcs (505 MU), 3Arcs (464 MU), and 4 Arcs (486 MU). Hence, reduced treatment time was observed in the one-arc VMATplan.

Conclusion: The conformity index and Organ-At-Risk (OAR) dose improved with an increase in the number of arcs from two to four. Therefore, utilizing a higher number of arcs in VMAT plans can enhance plan efficiency and reduce the dose to OAR. The results suggest that a 4-arc VMAT plan may serve as an alternative to the 2-arc plan, offering improved plan quality and reduced OAR dose in head and neck cancer. As the number of arcs increases the integral dose also increases, so only two arc is necessary for treating young patient to avoid secondary malignancy.

Keyword: VMAT; Arcs; Head and Neck cancer; Conformity Index; Homogeneity Index

Abbreviations: AAA: Analytic Anisotropic Algorithm; CI: Conformity Index; HI: Homogeneity Index; DVH: Dose Volume Histogram; VMAT: Volumetric Modulated Arc Therapy; PTV: Planning Target Volume; CT: Computer Tomography; IMRT: Intensity Modulated Arc Therapy; CTV: Clinical Target Volume; MV: Megavoltage; OAR: Organ at Risk Volume; PRV: Planning Organ at Risk Volume; TPS: Treatment Planning System; GTV: Gross tumor Volume; CECT: Contrast enhanced Computer Tomography; MLC: Multi-Leaf Collimator; PRO: Progressive Resolution Optimizer; DVH: Dose Volume Histogram; RTOG: Radiation Therapy Oncology Group; EBRT: External Beam Radiation Therapy; DICOM: Digital Imaging and Communication in Medicine

Introduction

Head and neck cancer is the seventh most common type of cancer worldwide and comprise of diverse group of tumors affecting the upper aero digestive tract. Head and Neck cancer include cancer in larynx, lips, throat, nose, salivary gland [1]. The type of treatment recommended depends on the location, site and type of cancer.

The head and neck cancer were selected because it’s a challenging scenario for treatment planning. Inappropirate dosing may result in either recurrence of disease or severe toxicity, thus it’s important to investigate the novel radiation delivery technique improves the dose coverage to target volume and minimal dose to OAR. Treatment options for patients with head and cancer include fractionated External Beam Radiotherapy (EBRT) or surgery (combined with EBRT), either with or without chemotherapy [1].

From all modalities used for treating cancer, radiation therapy seems to be a significant feature for effective treatment for Head and Neck cancer. With the introduction of modern radiation therapy technique such as Intensity Modulation Radiation Therapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT), radiation side effects during treatment are reduced. Therefore, IMRT and VMAT are chosen for radiation therapy for Head and Neck cancer.

The term Intensity-Modulated Radiation Therapy (IMRT) refers to a radiation therapy technique in which a non-uniform fluence is delivered to the patient from any given position of the treatment beam to optimize the composite dose distribution. The treatment criteria for plan optimization are specified by the planner and the optimal fluence profiles for a given set of beam directions are determined through inverse planning [2].

IMRT is highly effective in treating target structure with irregular contour, while reducing dose to healthy tissues. VMAT is a novel form of IMRT in which radiation treatment is delivered during gantry rotation with dynamic multi leaf collimator motion, variable dose rate and gantry speed modulation [2]. The main advantage of VMAT is less treatment time and reduced MU over conventional IMRT. Many studies have shown that VMAT can produce dosimetrically equivalent plans to IMRT for centrally located tumor such as prostate cancer, cervical cancer and head and neck cancer [3-4].

The beam on time for VMAT may be less than 3 mins. Since the Rapid arc optimization tries to maximize the gantry speed and dynamic MLC motion, we hypothesized that using more than two arcs, which would allow for a longer delivery time and more opportunity for modulation, might translate into further gains in plan quality. In search for better VMAT plans there are many parameters that the planar can modify, including the number of arcs.

Many considerations have been kept forward to enhance the plan quality in VMAT plans, including the number of beam arcs, may be chanced in quest for better volumetric modulated arc therapy plans. The present study aimed to compare the Dosimetric parameters of VMAT plans with varying number of arcs for head and neck cancer patients.

Materials and Methods

Patient Selection and Simulation

CT dataset was identified for twenty patients (15 males and 5 females) of head and neck cancers were selected for this study. All patients were immobilized with Klarity five push pin head and neck thermoplastic cast in the Head and Neck base frame. Patients were positioned in supine position with their arms alongside their body. All the CT scans were taken using contrast (CECT) which is use differentiate tumor volume from others. All of the CT dataset were acquired using a Simens Somato Scope CT (32 Slice) scanner. The CT image was taken at 3 mm slice thickness. The CT images were taken from supra orbital to trachea bifurcation for Head and Neck cancer. The data were transferred to the Eclipse 13.6 treatment planning system using DICOM format.

Delineation of Target Volume and Organ at Risk

Radiation oncologist contoured the target volume as per RTOG guidelines. Target structure such as Gross Tumor Volume (GTV), Clinical Target Volume (CTV), planning target volume and the Organ at Risk volume (OAR) were contoured. To ensure that the recommended dosage is administered to CTV and reduce the risk of treatment failure due to variability in position setup and movements of the organ during actual treatment, the planning target volume were obtained by expanding CTV, 5 mm in all directions expect in the direction of skin. The Organ at risk volume such as the spinal cord, Brainstem, parotid, Mandible, lips, cochlea were contoured by the radiation oncologist. An extra 5 mm margin was added to spinal cord and 3 mm added to brainstem as the planning organ at risk volume.

Treatment Planning

VMAT plans were created for all 20 patients using 6 MV X-ray photon beam energy from a Varian Truebeam linear accelerator which was equipped with an MLC with 120 leaves (of thickness 1cm for outer 10 pairs and 0.5 cm for inner 40 pair leaves). Four plans were created for each patient including single arc, dual arc, three arc and four arc plans optimized using Progressive Resolution Optimizer (PRO), eclipse treatment planning system version 13.6. (Varian medical system). The pictorial Representation of beam orientation of VMAT plans using single Arc, dual Arc, three Arc andfour Arc plans is shown in Figure 1. All the plans were optimized at a maximum DR of 600MU/min. The isocenter was taken as the center of the PTV. With a grid size of 2.5mm, the dose distribution was determined using the Anisotropic Analytic Algorithm (AAA) and the constraints were kept constant across all plans. The planning objective for PTV was at least 95% of the PTV volume receives 95% of the prescribed dose. During optimization the PTV was given the max priority and the Normal tissue objective was selected as, distance from target border as 3mm, start dose at 105% and end dose at 60%, dose fall off 3 mm. The normal tissue objective was given a priority of 100.